224 related articles for article (PubMed ID: 21255986)
41. Successful treatment of Netherton syndrome with dupilumab: A case report and review of the literature.
Wang J; Yu L; Zhang S; Wang C; Li Z; Li M; Zhang S
J Dermatol; 2022 Jan; 49(1):165-167. PubMed ID: 34862657
[TBL] [Abstract][Full Text] [Related]
42. Skin Biopsy in Netherton Syndrome: A Histological Review of a Large Series and New Findings.
Leclerc-Mercier S; Bodemer C; Furio L; Hadj-Rabia S; de Peufeilhoux L; Weibel L; Bursztejn AC; Bourrat E; Ortonne N; Molina TJ; Hovnanian A; Fraitag S
Am J Dermatopathol; 2016 Feb; 38(2):83-91. PubMed ID: 26825155
[TBL] [Abstract][Full Text] [Related]
43. The challenging management of a series of 43 infants with Netherton syndrome: unexpected complications and novel mutations.
Bellon N; Hadj-Rabia S; Moulin F; Lambe C; Lezmi G; Charbit-Henrion F; Alby C; Le Saché-de Peufeilhoux L; Leclerc-Mercier S; Hadchouel A; Steffann J; Hovnanian A; Lapillonne A; Bodemer C
Br J Dermatol; 2021 Mar; 184(3):532-537. PubMed ID: 32479644
[TBL] [Abstract][Full Text] [Related]
44. A compound heterozygous mutation of the SPINK5 gene in a Taiwanese boy with Netherton syndrome.
Chao SC; Tsai YM; Lee JY
J Formos Med Assoc; 2003 Jun; 102(6):418-23. PubMed ID: 12923596
[TBL] [Abstract][Full Text] [Related]
45. Netherton syndrome with extensive skin peeling and failure to thrive due to a homozygous frameshift mutation in SPINK5.
Geyer AS; Ratajczak P; Pol-Rodriguez M; Millar WS; Garzon M; Richard G
Dermatology; 2005; 210(4):308-14. PubMed ID: 15942217
[TBL] [Abstract][Full Text] [Related]
46. Netherton's syndrome and lepromatous leprosy: a mere coincidence?
de Oliveira FL; Vasconcellos BO; de Morais TS; Nascimento MB; Teles R; da Costa Nery JA; Miranda MJ; Azulay-Abulafia L
Int J Dermatol; 2013 Feb; 52(2):186-90. PubMed ID: 23347305
[TBL] [Abstract][Full Text] [Related]
47. Severe Hypernatremia as Presentation of Netherton Syndrome.
Di Nora A; Consentino MC; Messina G; Timpanaro T; Smilari P; Pavone P
Glob Med Genet; 2023 Dec; 10(4):335-338. PubMed ID: 38025195
[TBL] [Abstract][Full Text] [Related]
48. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides.
Komatsu N; Takata M; Otsuki N; Ohka R; Amano O; Takehara K; Saijoh K
J Invest Dermatol; 2002 Mar; 118(3):436-43. PubMed ID: 11874482
[TBL] [Abstract][Full Text] [Related]
49. A novel mutation in
Wang Y; Song H; Yu L; Wu N; Zheng X; Liang B; Wang P
Front Genet; 2022; 13():943264. PubMed ID: 36159989
[TBL] [Abstract][Full Text] [Related]
50. KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome.
Furio L; Pampalakis G; Michael IP; Nagy A; Sotiropoulou G; Hovnanian A
PLoS Genet; 2015 Sep; 11(9):e1005389. PubMed ID: 26390218
[TBL] [Abstract][Full Text] [Related]
51. Netherton Syndrome in a Mother and Her Two Children.
DeMoss J; Cooper L; Felts C; Wittenberg G
S D Med; 2022 Dec; 75(12):554-556. PubMed ID: 36893349
[TBL] [Abstract][Full Text] [Related]
52. Treatment of ichthyosis and hypernatremia in a patient with Netherton syndrome with a SPINK5 c.153delT mutation using kallikrein inhibiting ointment.
Tiryakioğlu NO; Önal Z; Saygili SK; Önal H; Ersoy Tunali N
Int J Dermatol; 2017 Jan; 56(1):106-108. PubMed ID: 26889743
[No Abstract] [Full Text] [Related]
53. A novel SPINK5 donor splice site variant in a child with Netherton syndrome.
Mintoff D; Borg I; Vornweg J; Mercieca L; Merdzanic R; Numrich J; Aquilina S; Pace NP; Fischer J
Mol Genet Genomic Med; 2021 Mar; 9(3):e1611. PubMed ID: 33534181
[TBL] [Abstract][Full Text] [Related]
54. A case of Netherton syndrome with intestinal atresia, a novel SPINK5 mutation, and a fatal course.
Nevet MJ; Indelman M; Ben-Ari J; Bergman R
Int J Dermatol; 2017 Oct; 56(10):1055-1057. PubMed ID: 28832989
[No Abstract] [Full Text] [Related]
55. [Netherton syndrome].
Serra-Guillén C; Torrelo A; Drake M; Armesto S; Fernández-Llaca H; Zambrano A
Actas Dermosifiliogr; 2006 Jun; 97(5):348-50. PubMed ID: 16956571
[TBL] [Abstract][Full Text] [Related]
56. Netherton syndrome: skin inflammation and allergy by loss of protease inhibition.
Hovnanian A
Cell Tissue Res; 2013 Feb; 351(2):289-300. PubMed ID: 23344365
[TBL] [Abstract][Full Text] [Related]
57. A proinflammatory role of KLK6 protease in Netherton syndrome.
Zingkou E; Pampalakis G; Charla E; Nauroy P; Kiritsi D; Sotiropoulou G
J Dermatol Sci; 2019 Jul; 95(1):28-35. PubMed ID: 31255470
[TBL] [Abstract][Full Text] [Related]
58. sQUIZ your knowledge!
Eur J Dermatol; 2012; 22(6):821, 822. PubMed ID: 23397609
[No Abstract] [Full Text] [Related]
59. Phase I study protocol for ex vivo lentiviral gene therapy for the inherited skin disease, Netherton syndrome.
Di WL; Mellerio JE; Bernadis C; Harper J; Abdul-Wahab A; Ghani S; Chan L; Martinez-Queipo M; Hara H; McNicol AM; Farzaneh F; McGrath J; Thrasher A; Qasim W
Hum Gene Ther Clin Dev; 2013 Dec; 24(4):182-90. PubMed ID: 24329107
[TBL] [Abstract][Full Text] [Related]
60. New mutation leading to the full variety of typical features of the Netherton syndrome.
Kogut M; Salz M; Hadaschik EN; Kohlhase J; Hartmann M
J Dtsch Dermatol Ges; 2015 Jul; 13(7):691-3. PubMed ID: 26031502
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
